Capital Area Research — Camp Hill, Pennsylvania

Capital Area Research is a clinical research site located in Camp Hill, Pennsylvania, United States 17011.

Crixeo Clinical Trials Trust Score: 27/100 (FAILING). This profile has not yet been claimed by the site owner.

Capital Area Research has participated in 53 clinical trials with 17 currently active.

Therapeutic areas: Percutaneous Coronary Intervention, Peripheral Endovascular Intervention, Atherosclerotic Cardiovascular Disease (ASCVD).

Sponsors: Duke University, Eli Lilly and Company, Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Camp Hill

Browse all research sites in Pennsylvania · View every site in Camp Hill

Sponsor Feasibility Report

Trust Score: 27/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Capital Area Research?

Capital Area Research has a Crixeo Trust Score of 27/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Capital Area Research conducted?

Capital Area Research has 53 clinical trials on record, with 17 currently active. Their work covers Percutaneous Coronary Intervention, Peripheral Endovascular Intervention, Atherosclerotic Cardiovascular Disease (ASCVD).

Is Capital Area Research accredited by Crixeo Clinical Trials?

Capital Area Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Capital Area Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.